Children under 15 account for 4.3% of all new and relapsed tuberculosis (TB) cases in the WHO European Region, which includes Europe and Central Asia, compared with 3.9% in 2022, a 10% increase. The finding was released this week in the 2025 Tuberculosis Surveillance and Monitoring Report. Veronica Cristea, MD The news has prompted urgent … Read more
TOPLINE: Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. METHODOLOGY: Researchers conducted a randomized, noninferiority, phase 4 trial to evaluate the efficacy and safety of dolutegravir plus lamivudine in untreated patients with HIV with no preliminary drug resistance testing. Overall, 223 participants (median … Read more